PropertyValue
?:abstract
  • Cautious optimism for neutralising antibodies Eli Lilly submitted a request to the US Food and Drug Administration for emergency use authorisation of its neutralising IgG1 monoclonal antibody (mAb) bamlanivimab in higher risk patients with mild to moderate covid-19, after what experts said were promising results Cardiology Societies advise on myocardial revascularisation The European Society of Cardiology and the European Association for Cardiothoracic Surgery agreed to review their guidance on treating patients with left main coronary artery stenosis in the light of emerging, longer term data on coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) Whether PCI is as safe and effective as CABG has been questioned since the BBC’s Newsnight revealed last year that unpublished data from the EXCEL trial showed that patients given stents were at greater risk of myocardial infarction
?:creator
?:journal
  • BMJ_:_British_Medical_Journal_(Online)
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Seven days in medicine: 7-13 October 2020
?:type
?:who_covidence_id
  • #868309
?:year
  • 2020

Metadata

Anon_0  
expand all